Forster Eliot 4
4 · Protalix BioTherapeutics, Inc. · Filed Sep 15, 2023
Insider Transaction Report
Form 4
Forster Eliot
Director
Transactions
- Award
Stock Options (Right to Buy)
2023-09-14+85,715→ 85,715 totalExercise: $1.75Exp: 2033-09-14→ Common Stock (85,715 underlying)
Footnotes (1)
- [F1]The shares of common stock underlying the stock options shall vest in 12 equal quarterly installments commencing upon the date of grant. The stock options are subject to accelerated vesting upon a corporate transaction or a change in control as described in the Protalix BioTherapeutics, Inc., Amended and Restated 2006 Stock Incentive Plan, as amended.